Global ophthalmology drugs & devices market to reach $36 billion by 2014 the global ophthalmology drug and devices market report analyzes the ophthalmology drugs and devices market over the period 2009-2014. The global ophthalmic drugs market segmentation is based on disease type (allergy, dry eye disorder, glaucoma, retinal disorder), and dispense type (over-the-counter, prescription) the global ophthalmic drugs market report provides market size (us$ million 2015 to 2023), market share, trends and forecast (cagr%, 2018 to 2023. The global ophthalmology market witnessed a dip during the economic downturn in 2008 and 2009 however, it is poised to grow at a stable rate mainly due to an increasing aging population, large pool of patients with eye diseases, changing demographics and geographical trends, and increased focus on combination therapies of drugs. Global ophthalmic drugs market: trend analysis and forecast to 2022 global ophthalmic drugs market: trend analysis and forecast to 2022 ophthalmic drugs are the drugs designed - market research report and industry analysis - 10925490.
The key factors driving the growth of ophthalmic drugs market are considered to be increasing geriatric population with rising global population, increase in prevalence of eye disorders, technological advancement, and increasing awareness in healthcare spending. The worldwide ophthalmology drugs market was roughly valued at usd 11 billion in 2015 and estimated to reach usd 16 billion by 2020 the strength and attractive view of the market is supported by (1) favorable macro trends (2) scientific innovation and (3) increasing interest and focus on. In 2017, the global ophthalmic therapeutic drugs market size was million us$ and is forecast to million us in 2025, growing at a cagr of from 2018 the objectives of this study are to define, segment, and project the size of the ophthalmic therapeutic drugs market based on company, product type. Zion market research has recently added the latest report, titled “global ophthalmic drugs market set for rapid growth, to reach value around usd 3452 billion by 2024“, which examines the overview of the various factors enabling growth and trends in the global industry.
Ophthalmic drugs market overview: global ophthalmic drugs market size was valued at $29,613 million in 2016, and is expected to reach $42,663 million by 2023, registering a cagr of 53% from 2017 to 2023 ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. An overview of the global market for ophthalmic therapeutic drugs analyses of global market trends, with data from 2013 and 2014, and projections of cagrs through 2019 investigation of one of the most important market drivers, combination therapies. According to the report, global demand for ophthalmic drugs market was valued at approximately usd 2503 billion in 2017 and is expected to generate revenue of around usd 3452 billion by end of 2024, growing at a cagr of around 470% between 2018 and 2024. Overview of the market: the europe ophthalmic drugs market size was around usd 83 billion in 2018 it is expected to grow at a cagr of 49% to reach usd 1054 billion by 2023 it captures 25% of the global market share. Industry insights the global ophthalmic therapeutics/drugs market size was valued at usd 227 billion in 2016 and is expected to grow at a cagr of 51.
London, aug 16, 2017 /prnewswire/ -- global ophthalmic drugs market: overview ophthalmic drugs is a growing market driven by rising prevalence of intraocular eye disorders mainly in elderly. This sector of the global ophthalmic drug market has grown to overtake glaucoma drugs as the second largest sector within the ophthalmic drug market glaucoma drugs : glaucoma is an umbrella term for a group of conditions which have in common a disease process where damage to the optic nerve causes visual impairment. The section “ophthalmic drugs market” includes an examination of the situation in major sections of the ophthalmic drugs market the markets in european union countries are examined in more detail, giving a timeline of financial results reported by major 3pl providers in 2017. Report description global ophthalmic drugs market: overview ophthalmic drugs is a growing market driven by rising prevalence of intraocular eye disorders mainly in elderly population like glaucoma, cataract, age-related macular degeneration, diabetic retinopathy, etc.
The global over-the-counter drugs market was valued at usd xx million in 2018 and is projected to reach a value of usd xx million by 2024, registering a cagr of. Global industry perspective, comprehensive analysis and forecast, 2017 - 2024” according to the report, global demand for ophthalmic drugs market was valued at approximately usd 2503 billion in 2017 and is expected to generate revenue of around usd 3452 billion by end of 2024, growing at a cagr of around 470% between 2018 and 2024. Global ophthalmic drugs market size was around usd 332 billion in 2018 it is expected to grow at a cagr of 52% to reach usd 4278 billion by 2023. The global ophthalmic drugs market is expected to grow at a cagr of 44% in the first half of the forecast period the market is expected to grow at a cagr of 48% from 2017-2028 the market is.
The report “global ophthalmic drug market: industry outlook 2018-2023” involves end-to-end data on cutting edge development perspectives from a 360-degree incline by covering all the fundamental blocks forming the ophthalmic drug market. The global ophthalmic drugs market is expected to register a cagr of 415% during the forecast period of 2018–2023 north america dominates the ophthalmic drugs market due to the presence of well-established healthcare facilities and rise in the geriatric population in the country. The report on ophthalmic drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global ophthalmic drugs market over the period of 2015 to 2023.